Senti Biosciences, Inc.SNTINASDAQ
Loading
Year-over-year SG&A expense growth
Latest
-14.98%
↓ 100% vs avg
Percentile
P32
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
19328.21%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -14.98% |
| Q2 2025 | 5.52% |
| Q1 2025 | -10.51% |
| Q4 2024 | 14.74% |
| Q3 2024 | 108.72% |
| Q2 2024 | -52.65% |
| Q1 2024 | -19.28% |
| Q4 2023 | -7.18% |
| Q3 2023 | -4.03% |
| Q2 2023 | 2.86% |
| Q1 2023 | -21.67% |
| Q4 2022 | 9.17% |
| Q3 2022 | -28.00% |
| Q2 2022 | 163.97% |
| Q1 2022 | -0.19% |
| Q4 2021 | -25.96% |
| Q3 2021 | 56.26% |
| Q2 2021 | 386487.44% |
| Q1 2021 | -99.96% |
| Q4 2020 | 0.00% |